Pharmas Get Additional Month To Comply With Indian Pricing Requirements
This article was originally published in PharmAsia News
Pharmaceutical companies have been granted an additional month to conform with National Pharmaceutical Pricing Authority requirements that they report manufacturing costs. Drug makers strongly objected to being required to meet the Jan. 31 deadline for supplying conversion, packing, processing and packing material costs to the agency. The NPPA has now extended the deadline to Feb. 28. The agency is required by law to revise its norms for the costs in determining the price caps to be imposed on drugs. (Click here for more
You may also be interested in...
Teligent has achieved a “pivotal step in our journey toward securing a strong financial future,” according to management, after recapitalizing its significant debt burden and gaining access to more cash.
Pfizer has entered into an agreement with Premier to supply five essential medications to US healthcare providers through Premier’s ProvideGx program. Both companies aim to secure supply of products specifically used by COVID patients.
Announcing his “first step to take on pricing of generic drugs,” billionaire Mark Cuban recently associated his name with a new US generics company “to show that capitalism can be compassionate.” In an exclusive chat with Generics Bulletin, the newly established company’s CEO Alex Oshmyansky revealed that they started working on the company “in stealth” since 2018.